Health Systems Strengthening Project Impact Evaluation 2015, Baseline Survey
Liberia, 2013 - 2015
Get MicrodataCreated on
Jan 16, 2021
Last modified
Jan 16, 2021
Page views
101288
Q106: H. Other (specify) (q106h_spec)
Data file: p_v_2
Overview
Valid:
85
Invalid:
0
Type:
Discrete
Start:
905
End:
954
Width:
50
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ADMINISTER ANTIPYRITIC | 2 |
2.4%
|
|
| AMOX 250MG | 1 |
1.2%
|
|
| AMOX 250MG,BLOOD TONIC | 2 |
2.4%
|
|
| AMOX, M-VIT, PCM,VERMOX | 2 |
2.4%
|
|
| AMOXCYCILLIN | 2 |
2.4%
|
|
| AMOXICILLIN,MULTI-VITAMIN | 1 |
1.2%
|
|
| ANTIBIOTIC, AMOX | 2 |
2.4%
|
|
| ANTIBIOTIC,AMOXICILLIN | 2 |
2.4%
|
|
| ANTIBIOTIC,MULTI-VITAMIN | 2 |
2.4%
|
|
| ANTIPYRATIC | 2 |
2.4%
|
|
| ANTIPYRETIC | 2 |
2.4%
|
|
| ANTIPYRETIC AND WAIT ON LAB RESULTS | 2 |
2.4%
|
|
| ARTEMETER IM,PARACETAMOL | 1 |
1.2%
|
|
| ARTEMETER,ORS,DICLOFENAC AND PCM | 2 |
2.4%
|
|
| ARTHEMETER | 1 |
1.2%
|
|
| BLOOD TRANSFUSION,DEWORM,ANTIBONE | 2 |
2.4%
|
|
| DEORANGE SYRUP,AMOXICILIN,D50 | 2 |
2.4%
|
|
| DICLOFENAC AND ARTEMETER | 2 |
2.4%
|
|
| M-VIT,AMOX | 1 |
1.2%
|
|
| M-VIT,VERMOX | 2 |
2.4%
|
|
| MULTI-VITAMIN,PCM | 2 |
2.4%
|
|
| MULTI-VITAMIN,PCM,COUGH SYRUP,CEPTRIXONE | 1 |
1.2%
|
|
| MULTIVITAMIN,PCM | 2 |
2.4%
|
|
| MULTIVITAMIN,VERMOX | 2 |
2.4%
|
|
| ORS,AMOXICINE,MULTI-VITAMIN | 2 |
2.4%
|
|
| PARACETAMOL | 4 |
4.7%
|
|
| PARACETAMOL,AMOXICILLIN | 4 |
4.7%
|
|
| PARACETAMOL,VERMOX | 1 |
1.2%
|
|
| PARACETAMOL,VITAMIN A,MEBENDAZOLE | 2 |
2.4%
|
|
| PCM | 15 |
17.6%
|
|
| PCM BID, | 1 |
1.2%
|
|
| PCM, AMOX | 1 |
1.2%
|
|
| PCM, AMP | 2 |
2.4%
|
|
| PCM, VERMOX | 1 |
1.2%
|
|
| PCM,AMOX,MULTI-VITAMINES | 1 |
1.2%
|
|
| PCM,MULTIVITAMIN | 2 |
2.4%
|
|
| PCM,TRANSFUSE IF BELOW ANTIBIOTICS | 2 |
2.4%
|
|
| PCN | 2 |
2.4%
|
|
| TRANSFUSE BLOOD, MEBENDAZOLE | 1 |
1.2%
|
|
| VERMOX,PCM | 2 |
2.4%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.